Objective: To study postnatal dexamethasone treatment effects on cognitive, neuropsychological and behavioral functioning at early school age in preterm children.
The glucocorticoid dexamethasone is a synthetic steroid used to prevent and treat bronchopulmonary dysplasia (BPD), a common respiratory complication following extremely preterm birth. Dexamethasone aids lung mechanics by increasing pulmonary compliance and decreasing inflammatory response, 1 and its use has shortened the duration of intubation, facilitated extubation and decreased the need for supplemental oxygen in preterm infants. Improved pulmonary compliance has resulted in decreased rates of pulmonary air leaks, patent ductus arteriosus and the combined outcome of death or BPD at 36 gestational weeks. [2] [3] [4] [5] Negative effects such as chronic hypoxia, 6 global cerebral volume reductions 7 and risk of neurodevelopmental delay or impairment have been reported by some investigators, [8] [9] [10] [11] but not by others [12] [13] [14] Moreover, adverse central nervous system effects such as altered neural cell numbers and synaptic function in forebrain regions reported in rats 1 and in humans [15] [16] [17] make glucocorticoid use in preterm infants a controversial treatment.
Long-term effects of dexamethasone on neurocognitive outcome remain understudied. An American Academy of Pediatrics statement that discourages dexamethasone treatment because of concerns arising from early literature reports 18 was recently moderated to reflect the apparent clinical usefulness in BPD management, and lack of consistent evidence for negative long-term cognitive effects. 19 BPD severity is an important predictor of neurocognitive outcome. 6 Impairments have been reported in intelligence, attention, executive function, perceptual-motor or visual-motor skill, gross motor function, memory, language and academic achievement, 6, 20, 21 with a greater likelihood of diffuse rather than focal dysfunction. Impairments in children treated with dexamethasone have been attributed to anomalous brain growth primarily affecting cerebral cortical gray matter and decreasing total cerebral volume, 17, 22 and adverse effects on neuronal growth and development. 16 Therefore, follow-up studies of preterm infants treated with dexamethasone are needed to extend cross-sectional studies conducted primarily in infancy and at preschool age in order to better understand effects of glucocorticoid treatment in this at-risk population at school age. The few school age cognitive outcome studies of dexamethasone treatment resulted in inconsistent conclusions, and most were not conducted exclusively with extremely low birth weight (ELBW) survivors. [23] [24] [25] [26] O'Shea et al. 25 observed a slight IQ advantage at ages 4 and 8 for dexamethasone-treated compared with untreated children born with <1500 g weight, and found no differences in behavior. Yeh et al. 26 reported that dexamethasone-treated children born with 500 to 1999 g weight had significantly lower IQ at age 8 than those untreated, although no differences were found in language ability or adaptive behavior. Jones et al. 24 found no cognitive or behavioral differences between dexamethasonetreated and untreated adolescents. Gross et al. 23 concluded that dexamethasone-treated children born with <1250 g weight with improved lung function had better neuropsychological and behavioral outcomes than untreated survivors at age 15, because of decreased BPD-related neurological abnormalities. Notably, standardized neuropsychological instruments were rarely administered in school-age follow-up studies despite their ability to enhance our understanding of dexamethasone's late neurocognitive effects.
Our objective for this retrospective observational cohort single-center study was to compare dexamethasone-treated (DEX) and dexamethasone-untreated (NODEX) preterm survivors born at ELBW (<1000 g) with term-born (TERM) children on a range of cognitive, neuropsychological and behavioral measures at early school age. The literature on combined ELBW and higher birth weight preterm survivors [23] [24] [25] [26] led us to hypothesize that (1) children born at ELBW, both dexamethasone-treated and untreated, would perform worse than term-born children across each measure and (2) dexamethasone-treated children would perform worse than dexamethasone-untreated children.
Methods

Participants
With Institutional Review Board approval, we recruited by mail a single center cohort of 228 children (120 ELBW; 108 TERM) born between January 1998 and December 2003. Participants who were term born at the same hospital were recruited for the comparison group through posted IRB-approved flyers in the community and randomly selected mailings. A sensitivity analysis between ELBW participants and all ELBW non-participants found that there were no differences for any medical variable recorded in the medical charts, except that significantly more participants were inborn (P ¼ 0.023) and male (P ¼ 0.021). Exclusion criteria were brain tumor, genetic disorder, severe sensorineural impairment or non-English speaking. In all, five DEX participants had incomplete testing because of severe sensorineural delay (n ¼ 3) or autism (n ¼ 2), and one NODEX participant was selectively mute. Therefore, analyses were conducted on 114 ELBW and 108 TERM participants; ELBW participants were either (1) dexamethasone-treated (DEX; n ¼ 60) or (2) 
Procedure
After obtaining parental informed consent and child assent, the following standardized tests of general cognition and neuropsychological function were administered by experienced research assistants blinded to participant group and preterm status.
Differential Ability Scales (DAS): 27 The DAS is a multi-subtest general cognitive battery that provides General Conceptual Ability, Verbal Cluster, Nonverbal Reasoning Cluster and Spatial Cluster summary scores as well as additional diagnostic and achievement subtest scores.
Wechsler Intelligence Scale for Children-IV (WISC-IV) Digit Span subtest:
28 Digit Span is an untimed measure of forward and backward number repetition, auditory attention and verbal working memory.
Corsi block-tapping task: 29 Corsi block-tapping is a non-verbal analogue of digit span that measures visuospatial span and spatial working memory.
Beery-Buktenica test of visual-motor integration (VMI), Fifth Edition: 30 VMI is an untimed test of graphomotor proficiency requiring copying of increasingly complex geometric designs.
Purdue Pegboard test of manual dexterity: 31 Purdue Pegboard is a timed test requiring rapid peg placement into a formboard using each upper extremity independently followed by bilateral performance.
Test of Everyday Attention for Children (TEA-Ch): Sky Search subtest:
32 Sky search is a timed selective attention task requiring visual scanning and rapid circling with a pen of 'spaceship' pairs embedded within distracter pairs, and inhibition of response to non-matching pairs.
Comprehensive Test of Phonological Processing (CTOPP): Elision subtest:
33 Elision is an untimed task requiring single-word repetition and then production of that word, in the absence of a specified phoneme.
Letter fluency: 34 Letter fluency is a timed (60-s) verbal single-word retrieval in response to the letters F, A or S.
Noun fluency: 34 Noun fluency is a timed (60-s) verbal-word retrieval of animal exemplars.
Behavior Rating Inventory of Executive Functioning (BRIEF):
35 BRIEF is a questionnaire that includes parent and teacher report forms that yields summary behavioral regulation, metacognition and global executive composite scores.
Behavior Assessment System for Children-2 (BASC-2):
BASC-2 is a parent report questionnaire that yields composites scores for externalizing problems, internalizing problems, behavioral symptoms and adaptive skills.
Statistical analysis
The w 2 -test was used to assess group differences in categorical demographic and medical variables. Analysis of variance was used to test for differences in continuous demographic and medical variables. For incomplete performance, a score 3 standard deviations below the normative mean was assigned for missing data. Multivariate analysis of variance was used to test for differences between the three groups on DAS, neuropsychological and behavioral variables. Analysis of covariance, with gestational age as a covariate, was used to determine whether differences in outcome variables between total ELBW and TERM groups were explained by degree of prematurity. Post-hoc comparisons were Bonferroni-corrected. Effect sizes were calculated using the partial Z 2 statistic. On variables showing significant differences between the DEX and NODEX groups, stepwise regressions were performed with demographic and medical variables entered as predictors. Predictor variables were gestational age, birth weight, length of stay, dexamethasone treatment, ventriculomegaly/hydrocephalus, periventricular leukomalacia, intraventricular hemorrhage (grade 3 or 4), maternal education, gender and race/ethnicity. Alpha was set at 0.05. 
Results
No significant DEX, NODEX and TERM group differences were found for the demographic variables of gender, maternal age at delivery, handedness or child's age at testing (see Table 1 ). The DEX and NODEX groups had fewer Caucasian participants than TERM (P ¼ 0.005), and maternal education (P ¼ 0.001, Z p 2 ¼ 0.061) was lower for DEX than TERM (P<0.001). Groups differed in birth weight (P ¼ 0.001, Z p 2 ¼ 0.952) with DEX and NODEX lower than TERM (P<0.001), and in cesarean delivery (P<0.001) with rates higher in DEX and NODEX than TERM (P<0.001). Gestational age (P<0.001, Z p 2 ¼ 0.945) was longer for TERM than for DEX and NODEX (Ps<0.001), and NODEX gestational age was longer than DEX (P<0.001). DEX and NODEX differed for three medical variables examined; DEX had higher rates than NODEX of BPD (P<0.001), surfactant therapy (P ¼ 0.005) and retinopathy of prematurity (P<0.001).
General conceptual ability DAS scores are presented in Table 2 . Analysis of variance indicated differences on DAS General Conceptual Ability (P<0.001) and all three DAS cluster scores, with large effect sizes: Verbal (P<0.001), Nonverbal Reasoning (P<0.001) and Spatial (P<0.001). Post-hoc tests found DEX and NODEX subgroups performing worse than TERM on all clusters (all P's<0.001). Differences were found for all subtests that contribute to cluster scores, with DEX and NODEX performing worse than TERM in each instance (all Ps<0.001). DEX and NODEX were not different on Nonverbal Reasoning (P ¼ 0.3), although they did differ on the contributing Recall of Designs subtest (P ¼ 0.007). The regression model for Recall of Designs performance (P<0.001) indicated length of stay (P<0.001) and lower maternal education (P ¼ 0.026) were significant predictors of poor performance.
Differences were found on supplemental DAS subtests of Immediate Recall of Objects (P<0.001) and Speed of Information Processing (P<0.001); DEX and NODEX performed below TERM (all Ps<0.001) but DEX and NODEX did not differ. Analyses of the three DAS academic achievement subtests found differences for Spelling, Word Reading and Basic Number Skills, with both ELBW subgroups performing below TERM on each measure (all Ps<0.001), and DEX below NODEX on Basic Number Skills (P ¼ 0.035). The regression model for Basic Number Skills performance (P<0.001) indicated length of stay (P<0.007) and male gender (P ¼ 0.039) were significant predictors of poor performance.
Neuropsychological measures
Neuropsychological scores are shown in Table 3 significant predictors of poor performance. The Purdue Pegboard-dominant hand regression model (P<0.001) indicated birth weight (P<0.001) and ventriculomegaly/hydrocephalus (P ¼ 0.004) were significant predictors of poor performance. Table 3 shows mean scores on the parent and teacher BRIEF and BASC-2 reports. BRIEF parent scores differed for the Behavioral Regulation Index, Metacognition Index and Global Executive Composite; for each, DEX and NODEX were rated as having more difficulty than TERM (all Ps<0.001). BRIEF teacher scores were obtained for 40 DEX, 39 NODEX and 81 TERM participants. Differences were found for Behavioral Regulation Index (P ¼ 0.006); teachers rated DEX (P ¼ 0.007) but not NODEX as having more difficulty than TERM. For Metacognition Index (P<0.001) and Global Executive Composite (P<0.001) teachers rated both DEX (P<0.001) and NODEX (P<0.028) as having more difficulty than TERM.
Executive function and behavioral questionnaires
BASC-2 parent reports were obtained for 58 DEX, 50 NODEX and 106 TERM children. Differences were found for Externalizing Problems (P ¼ 0.003) and Internalizing Problems (P ¼ 0.001); NODEX (all Ps<0.01), but not DEX, differed from TERM. For Behavioral Symptoms Index and Adaptive Skills, both DEX and NODEX were rated as having more difficulty than TERM (all Ps<0.001).
Gestational age Because differences were found in gestational weeks at birth (ELBW<TERM), analysis of covariance was performed with this variable as the covariate. After analysis of covariance, no DAS, BRIEF, or BASC-2 measure showed significant group differences. Only one neuropsychological test comparison remained significant, Wechsler Intelligence Scale for Children-IV digit span backward (P ¼ 0.008, Z p 2 ¼ 0.043); DEX and NODEX performed below TERM.
Discussion
We found dexamethasone-treated and dexamethasone-untreated ELBW participants performed below term-born participants on a wide range of cognitive, neuropsychological and behavioral measures: general conceptual ability, academic achievement, phonological processing, motor and visuomotor skill, information processing speed, executive function (fluency, working memory), immediate memory and behavior. Although preterm children are at risk for lowered cognitive scores, 37 our ELBW cohort's general conceptual ability fell within average limits for both the dexamethasone-treated and untreated groups. However, consistent with reports of neuromotor, attentional and working memory weaknesses following preterm birth, [37] [38] [39] our ELBW participants performed below average on measures of manual coordination/ dexterity and spatial working memory.
We found partial support for our second hypothesis that participants who received postnatal dexamethasone would perform more poorly than dexamethasone-untreated participants. Those receiving dexamethasone performed less well than those untreated on measures of immediate visual memory, visual-motor skill, manual dexterity (dominant-hand) and mathematics skill. However, stepwise regressions indicated that variables other than dexamethasone made an important contribution to these findings: length of stay and gender predicted ELBW performance in mathematics and visual-motor integration; length of stay and maternal education predicted immediate visual memory performance; and birth weight and ventriculomegaly predicted manual dexterity. Thus, illness severity (using length of stay as proxy), male gender (an established risk factor for poorer preterm neurodevelopment), maternal education and a diagnosis of ventriculomegaly also explained the differences between our postnatal dexamethasone treated and untreated groups. Previous reports of negative dexamethasone effects might therefore be partially explained by various illness severity factors and socioenvironmental variables, as such factors have rarely been studied in this population although their influence may be consequential.
Parents and teachers of ELBW and term-born children reported no executive function deficit, although greater concern was endorsed about such functioning in ELBW children than in term-born children. Additionally, parents of ELBW children had greater concern about behavioral symptoms and adaptive skills, and parents of dexamethasone-untreated children had more concern about externalizing problems (for example, hyperactivity and aggression). Notably, scores fell within average limits for all groups suggesting that behavioral concerns reported by parents of ELBW children may be subtle but were perceived to be present.
Methodological differences may explain the discrepancy between our findings and previous reports. Often, preterm studies of dexamethasone use were conducted with young children using an infant development measure with poor predictive validity; 8, 40 cohorts were mostly heterogeneous for birth weight or gestational age range, age at study or age at follow-up; non-standardized glucocorticoid treatment protocols were used; also, there was reliance on diverse outcome measures, including subjective parental report rather than standardized tests.
Further research is needed to clarify the effects of timing, dosage and duration of postnatal corticosteroid therapy on long-term cognitive, neuropsychological and behavioral outcome. Recent meta-analyses noted few follow-up studies have been conducted beyond the preschool years, and that findings to date suggest corticosteroid administration in the first week of life increases risk of cerebral palsy and neurocognitive deficit. 41, 42 Moreover, as deficits at school age are not predicted well by infant and toddler scales, 43 carefully designed longitudinal studies initiated at preschool age and that extend into the critical school age years are needed. Our study strengths included measurement of a broad range of neuropsychological and behavioral functions at early school age in a cohort homogeneous for birth weight (<1000 g) whose participants were either dexamethasone-treated or dexamethasoneuntreated, compared with a term-born group recruited from the same hospital and, therefore, demographic region. Additionally, supplementary third-party behavioral data were obtained from both parents and teachers. Potential protective factors included that ELBW participants had a neonatal course absent severe intracerebral complication and high mean maternal education (range: 14.8 to 16.2 years) across all three groups, perhaps elevating neurocognitive results overall. Study limitations were a small sample size typical of single center studies, and elevated mean general conceptual ability in our term-born controls (>1 s.d.) that likely limited appreciation for our ELBW cohort's performance weaknesses.
In conclusion, studies of cognitive, neuropsychological and behavioral outcomes at early school age in ELBW cohorts who received postnatal dexamethasone treatment have been few and inconclusive, leading to controversy about postnatal corticosteroid use. Current recommendation is that glucocorticoid use be initiated only if there is a high risk of BPD, 18, 19 but which infants will benefit most remains to be determined. Our ELBW participants who were at high risk of poor respiratory prognosis and treated with dexamethasone performed not significantly different from those who were untreated on most measures. In those instances when poorer outcomes were found in dexamethasone-treated children, demographic and socioenvironmental factors were also influential, suggesting that dexamethasone-treatment alone was not responsible for adverse outcome in our cohort. Our findings add to the literature regarding the cognitive, neuropsychological and behavioral effects at school age of ELBW survivors treated or untreated with postnatal dexamethasone, and are consistent with reports that dexamethasone exposure itself does not fully explain an increased risk of long-term neurodevelopmental impairment in this population. [12] [13] [14] Other factors are influential and require additional study, preferably through a prospective longitudinal design that spans preschool to school age and that extends general intelligence testing to include finer and more diverse neuropsychological and behavioral measures.
